원료 사전 탐색/beeswax/BEESWAX
Tier 1 Monograph · SSOT 15 FieldsRaw .md (GEO) ↗
동물 유래 (Animal)

BEESWAX

식약처 한글 표준명: 비즈왁스
향료피부컨디셔닝제점도조절제결합제유화안정제
[식약처 공정서 기원 및 정의] 이 원료는 서양꿀벌 (Apis mellifera)의 벌집에서 얻은 납을 정제하여 얻은 것이다. 표백한 것은 화이트왁스(백납), 표백하지 않은 것은 옐로우왁스로 불린다.
[EU CosIng Official Definition] Beeswax is the purified wax from the honeycomb of the bee, Apis mellifera , free from all other waxes.
결론 선행 Executive Regulatory & Safety Fact BoxAEO / GEO CITATION ANCHOR

화장품에서 비즈왁스 (BEESWAX)의 글로벌 배합 한도와 핵심 효능·처방 기준은 무엇인가요?

비즈왁스(표준 INCI: BEESWAX, CAS 번호: 8006-40-4)은 화장품 처방에서 주로 향료, 피부컨디셔닝제, 점도조절제 목적으로 배합되는 핵심 원료입니다. 한국 식약처(미규제) 및 유럽 CosIng(미규제) 등 6대 권역 법정 기준 하에 관리되며, 통상 0.3–15%(적정 pH 4–8) 범위에서 안정적으로 처방됩니다.

7대 갈래 국가별·용도별 공식 전성분 라벨 표기명 매트릭스

각국 1차 법원 고시 정본 · 기계번역·임의 음차 0건
7-Track Official Statutory Label Names for BEESWAX
국가·규제 트랙공식 고시 전성분 표기명원클릭 복사
① 한국 (MFDS 화장품 한글 표준명)비즈왁스
② 한국 구명칭 (개정 전 이력 · 301 리다이렉트)——
③ 유럽 (EU CosIng EC 1223/2009)CERA ALBA
④ 미국 일반화장품 (US PCPC / MoCRA INCI)BEESWAX
⑤ 미국 OTC (FDA Active Ingredient Monograph)— (비-OTC 일반 화장품 원료)—
⑥ 중국 (NMPA IECIC 표준 중문명)蜂蜡
⑦ 일본 일반화장품 / 의약부외품 (JCIA / MHLW)ミツロウ · [QD: サラシミツロウ]

Layer 1 — 글로벌 6대 권역 법정 배합 한도 및 규제 상태

Layer 1 Statutory Regulatory Limits Across 6 Regions for BEESWAX
권역규제 상태배합 한도제한 조건 및 1차 법원 출처
한국 (MFDS)미규제GMP공식 화장품 원료 목록 등재 (GMP 기준 사용)
유럽 (CosIng)미규제GMP공식 화장품 원료 목록 등재 (GMP 기준 사용)
미국 (FDA/CIR)미규제GMP공식 화장품 원료 목록 등재 (GMP 기준 사용)
중국 (NMPA)등재·허용GMPIECIC Entry #2338
일본 (MHLW)미규제GMP공식 화장품 원료 목록 등재 (GMP 기준 사용)
아세안 (ACD)미규제GMP공식 화장품 원료 목록 등재 (GMP 기준 사용)
⚠️ 참조용 안내 (법적 면책 공지): 이 사전의 성분명·규제 한도·배합 가이드는 연구·개발 참조용으로만 제공됩니다. 각국 고시 개정 시차나 데이터 오기·누락이 있을 수 있으므로, 실제 제품 처방·라벨 표기·인허가 전에는 반드시 관할 기관(식약처 등)의 최신 공식 고시 원문을 직접 확인하시기 바라며, 본 사전의 정보를 잘못 사용하여 발생하는 문제에 대해 운영 주체는 법적 책임을 지지 않습니다.
제형군별 사분위수(Min–Q1–Median–Q3–Max) 분포 그래프

Layer 3 제형군별 통상 배합 농도(%) 레인지 & Layer 1 법정 한도 대조

O/W · W/O 에멀전·크림n=9
Min 0.3% · Q1 1% · Median 1.5% · Q3 5% · Max 15%
자외선차단·색조n=16
Min 0.5% · Q1 2% · Median 2.5% · Q3 4.65% · Max 10%
O/W · W/O 에멀전·크림 — 유화 로션·크림 제형 구조 형성 및 피부 컨디셔닝
공식 검증 원천: Global Starter Formulation Library Statistical Distribution (n=9, GRANT 6 · SEPPIC 2 · ELEMENTIS 1) (cir_safety) · GRANT 6 · SEPPIC 2 · ELEMENTIS 1
권장 중앙값: 1.5%

Layer 3 — 제형군별 통상 배합 농도(n≥5 사분위수) & 물리화학·상용성 가이드

Layer 3 Formulation Concentration Quartiles by Product Category for BEESWAX
제형군 분류Min – Q1 – Median – Q3 – Max (%)처방 역할 및 기전Source ID
제형군 B — 유화 로션 · 에멀전 · 크림 (O/W · W/O)0.3% · 1% · 1.5% · 5% · 15%유화 로션·크림 제형 구조 형성 및 피부 컨디셔닝Global Starter Formulation Library Statistical Distribution (n=9, GRANT 6 · SEPPIC 2 · ELEMENTIS 1)
제형군 D — 자외선차단제(선크림) · 색조 · 파운데이션0.5% · 2% · 2.5% · 4.65% · 10%선케어·색조 메이크업 분산 안정화 및 발림성 조절Global Starter Formulation Library Statistical Distribution (n=16, GRANT 14 · ELEMENTIS 2)
피부 투과 과학 시각화 (Bos & Meinardi 500 Dalton Rule)MW: Macro/Complex · LogP: N/A

각질층 장벽 투과 깊이 & 바이오 스피큘 경피전달(DDS) 시뮬레이션

각질층 (Stratum Corneum · 10~20 µm)500 Dalton 장벽 (고분자·친수성 성분 차단)생존 표피층 (Viable Epidermis · 50~100 µm)멜라닌세포 · 각질형성세포 타깃 (미백·장벽·턴오버)진피 유두층 (Papillary Dermis · 150~300 µm)섬유아세포 콜라겐 I/III · 엘라스틴 · PDRN 재생 타깃표피~상부 진피 확산 (<500 Da)
분자량(MW) & 친유성(LogP) 투과 판정
저분자 영역 (320 Da ≤ 500 Da) — 각질층 수동 확산 가능

단독 도포 시 각질층 세포간 지질(Brick & Mortar) 경로를 통해 확산됩니다. 500 Dalton 이상 친수성 분자는 각질층 표면에 주로 머물러 보습·보호막 역할을 수행합니다.

예상 도달 깊이
40–90 µm
권장 전달 시스템
Polyol Enhancer / Serum
계면화학 · pH · 열역학 공정 시각화

pH 안정성 스펙트럼(0~14) · 가열 한계 게이지 · HLB 콜로이드 상거동

Water or glycol phase soluble/dispersible
적정 처방 pH 안전 윈도우 (pH 0 ~ 14 스펙트럼)pH 4.0 – 8.0
0245.5791114

권장 구간 밖(pH < 4 또는 pH > 8)에서는 가수분해·점도 저하·이온 탈리 위험이 증가합니다.

공정 가열 한계 온도 (Max Process Temp)≤ 50°C
25°C45°C60°C75°C85°C100°C

최대 50°C 가열 공정에서 열적 안정성이 유지됩니다.

계면활성·유화 HLB 스펙트럼 (0 ~ 20) & 미셀/액정 배열 시뮬레이터
O/W 수중유형 미셀 에멀전 (수분 크림·로션)
HLB 11.5
W/O (3–6)Lamellar (8–10.5)O/W Emulsion (11–15)Solubilizer (15–19)O/W Droplet
생화학 신호전달 경로 (Biochemical Pathway Map)

세포·분자 타깃 작용 기전 플로우 다이어그램

1. 각질층·표피 작용→ 촉진·활성 (Activation)
각질층 세포간 지질 & 수분 결합 네트워크
→
경피수분손실(TEWL) 억제 및 피부결 개선
2. 염증 매개체 조절⊣ 억제·차단 (Inhibition)
외부 자극 유도 산화 스트레스(ROS) 및 사이토카인
⊣
피부 진정 및 항상성 유지
처방 온톨로지 네트워크 그래프

권장 시너지(🟢 실선) & 배합 금기·주의(🔴 점선) 인터랙티브 관계도

+ GLYCERIN+ CAPRYLIC/CAPRIC TR…+ TOCOPHEROL✕ 처방 내 극단적 pH 조건 및 고농도…BEESWAX
노드 인터랙션 가이드

🟢 초록색 시너지 원료 노드를 클릭하면 해당 원료 모노그래프로 즉시 이동하며, 🔴 붉은색 점선 노드를 클릭하면 화학적 상충(석출·변색·실활) 메커니즘을 표시합니다.

대표 상용명 참고 (상표법 제90조 제1항 제2호 설명적 표기)
BEESWAX

상용명 표기는 상표법 제90조 제1항 제2호에 의거하여 연구원에게 원료 등급·규격을 설명하기 위한 참고용이며, 각 상표의 권리는 해당 원료사에 귀속됩니다.

학술·독성·제형 종합 요약 (Tier 1~3 탄력 요약)

Tier 1 Synthesis

이 원료에 매칭된 PubMed 동료심사 논문 초록과 공인 독성 보고서만으로 작성된 학술 요약입니다.

■ [1. 화학적 정체성 및 규격 (Chemical Identity & Standard Nomenclature)] - 표준명: 비즈왁스 | INCI: BEESWAX | CAS No.: 8006-40-4 | EC No.: 232-383-7 - 기원 및 분류: ANIMAL | 주요 기능: 향료, 피부컨디셔닝제, 점도조절제, 결합제, 유화안정제 - 물리화학 스펙: 분자식 복합 조성이거나 단일 화학식 미지정 | 분자량 고분자/복합물(Polymer/Complex) | 친수/친유 밸런스 특화 | 이온성: non-ionic | CosIng/MFDS 등재 - 7대 권역 공식 라벨 표기: KR [비즈왁스] · EU [CERA ALBA] · US [BEESWAX] · CN [蜂蜡] · JP [ミツロウ] · JP의약부외품 [サラシミツロウ] ■ [2. 피부과학적 작용 기전 및 제형 내 역할 (Mechanism of Action & Function)] - 이 원료는 서양꿀벌 (Apis mellifera)의 벌집에서 얻은 납을 정제하여 얻은 것이다. 표백한 것은 화이트왁스(백납), 표백하지 않은 것은 옐로우왁스로 불린다. 물리화학적 분류상 기원(animal)에 기반하여 피부 장벽 및 제형 매트릭스 내에서 고유한 기능(향료, 피부컨디셔닝제, 점도조절제, 결합제, 유화안정제)을 수행하며, 계면 안정화·보습·피부 컨디셔닝 또는 유효성분 전달에 기여합니다. ■ [3. 글로벌 6대 권역 법정 규제 및 안전성 한도 (Layer 1 & Layer 2 Regulatory Matrix)] - 6개국 요약: KR: NONE | EU: NONE | US: NONE | CN: ALLOWED | JP: NONE | ASEAN: NONE (중국 IECIC(2025) 등재번호 2338 (蜂蜡)) - 6대 주요 권역(KR·EU·US·CN·JP·ASEAN) 별도 배합금지/특수제한 고시 없음 (GMP 일반 안전 기준 내 배합 허용). - 공인 안전성·역사적 사용 농도(Layer 2): 제형 목적 및 GMP 안전성 평가 범위 내 적량(QS) 사용 ■ [4. 제형군별 통상 배합 가이드 (Layer 3-A Formulation Dosage Guide)] - [emulsion_cream] 권장 범위: 0.3 ~ 15.0% (중앙값 1.5%, 근거: Global Starter Formulation Library Statistical Distribution (n=9, GRANT 6 · SEPPIC 2 · ELEMENTIS 1)) — 유화 로션·크림 제형 구조 형성 및 피부 컨디셔닝 - [sun_color] 권장 범위: 0.5 ~ 10.0% (중앙값 2.5%, 근거: Global Starter Formulation Library Statistical Distribution (n=16, GRANT 14 · ELEMENTIS 2)) — 선케어·색조 메이크업 분산 안정화 및 발림성 조절 ■ [5. 연구원 공정 설계 · 안정성 · 배합 금기 (Layer 3-B Process & Compatibility)] - 투입 공정(Phase): Water Phase or Cool-down Phase (< 45°C) - 적정 pH 구간: pH 4.0 ~ 8.0 | 공정 내열 온도: 최대 50°C | 전해질(염) 내성: MEDIUM - 배합 주의/금기: 처방 내 극단적 pH 조건 및 고농도 전해질과의 상용성 사전 확인 권장 - 시너지 추천 원료: GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL | 참고 상용 원료명: BEESWAX ■ [6. 학술 논문 및 공인 문헌 근거 (Peer-Reviewed Literature & Compendia)] - PMID 36999457 (2023, J Cosmet Dermatol): A review of the use of beeswax in skincare. - PMID 42074130 (2026, Int J Mol Sci): Beeswax in Pharmaceutical Sciences: A Comprehensive Review of Its Chemical Composition, Functional Applications, Types, - PMID 41892232 (2026, Biology (Basel)): Brood-Derived Fat Extracts from Apis mellifera as Sustainable Alternatives to Beeswax in Topical Nanostructured Lipid Ca

근거 동료심사 학술 논문 (미국 NIH PubMed) (13)

A review of the use of beeswax in skincare. [PMID: 36999457 · 2023]
Nong Y, Maloh J, Natarelli N, Gunt HB, Tristani E, Sivamani RK · J Cosmet Dermatol (2023)
[핵심 요약] 비즈왁스는 근로자 벌에서 분비되는 천연물질로 스킨케어에서 폐색제, 보습제, 연화제로 작용하며 경표피 수분손실을 최소화하고 피부를 부드럽게 하고 진정시킨다. 피부염, 건선 등의 일반적인 피부질환 증상 완화에 도움이 되는 것으로 나타났으며, 임상 연구에서 국소 비즈왁스가 피부장벽 지원에 이점을 보여준다.

Beeswax is a naturally occurring product secreted from worker bees that has varied uses in modern day. In skincare, its function ranges from its role as an occlusive, helping to create a semi-occlusive skin barrier that minimizes transepidermal water loss; as a humectant, locking in hydration; and an emollient to soften and soothe the skin. As a natural substance, its use has been shown to help alleviate symptoms associated with common cutaneous conditions like dermatitis, psoriasis, and overgrowth of normal skin flora. In this narrative review, we aim to describe current uses of beeswax in skincare that has been published in the literature. A review of beeswax related publications was performed by searching the PubMed database studies. A total of five clinical studies were included with three studies on animals and two studies in humans. Several studies show the benefits of topical beeswax in supporting the skin barrier. Beeswax can be a low-cost, natural ingredient for use in products. Further studies with topical beeswax are warranted.

Beeswax in Pharmaceutical Sciences: A Comprehensive Review of Its Chemical Composition, Functional Applications, Types, and Formulation Roles [PMID: 42074130 · 2026]
Huanbutta K, Chuttong B, Danmek K, Sriamornsak P, Suwanpitak K, Sangnim T · Int J Mol Sci (2026)

Beeswax, a complex natural secretion primarily derived from Apis mellifera and Apis cerana , has evolved from an ancient remedy into a multifunctional excipient and bioactive material in modern pharmaceutical sciences. This review evaluates its physicochemical properties, pharmaceutical applications, and emerging biomedical potential, while addressing current quality and regulatory challenges. A narrative review was conducted by analyzing literature on the chemical composition, functional properties, conventional uses, advanced drug delivery applications, pharmacological activities, and quality control of beeswax, emphasizing structural characteristics, formulation roles, and integration into innovative delivery technologies. Beeswax is a lipid-based matrix composed of over 300 constituents, including wax esters, hydrocarbons, and free fatty acids, conferring thermoplasticity, biocompatibility, and structural stability. Traditionally, it functions as a stiffening agent, viscosity modifier, and emulsion stabilizer in topical formulations, forming an occlusive barrier that enhances skin hydration. In advanced systems, it serves as a solid lipid matrix in nanostructured lipid carriers (NLCs), microspheres, and 3D-printed tablets, enabling controlled drug release and improved bioavailability of lipophilic compounds. It also exhibits antimicrobial, anti-inflammatory, and wound-healing activities, while beeswax-derived policosanols show potential cardiovascular and gastroprotective benefits. However, concerns regarding paraffin adulteration and pesticide contamination highlight the need for stringent analytical and regulatory oversight. With rigorous quality control and sustainable sourcing, beeswax remains a versatile, eco-friendly material bridging traditional medicine and advanced pharmaceutical innovation.

Brood-Derived Fat Extracts from Apis mellifera as Sustainable Alternatives to Beeswax in Topical Nanostructured Lipid Carriers [PMID: 41892232 · 2026]
Samianpet P, Somwongin S, Phongphisutthinant R, Chaipoot S, Wiriyacharee P, Tima S, Anuchapreeda S, Juntrapirom S, Kanjanakawinkul W, Rades T, Chaiyana W · Biology (Basel) (2026)

This study evaluated Apis mellifera brood fat extracts as a sustainable alternative to beeswax for anti-inflammatory topical delivery, including their formulation into nanostructured lipid carriers (NLCs). Brood fat was extracted using acetone, ethyl acetate (EA), and hexane, and the resulting extracts were characterized for fatty acid composition and physicochemical properties. Safety was assessed using the hen's egg chorioallantoic membrane test and cytotoxicity testing in RAW 264.7 macrophages. Anti-inflammatory activity was assessed by inhibition of lipopolysaccharide-induced interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-&#x3b1;) production. The most suitable extract was formulated into NLCs using sugar squalane as liquid lipid, and the effects of lipid ratio and preparation method were investigated. The results showed that the ethyl acetate extract had the highest yield. Compared with beeswax, all fat extracts exhibited a favorable oleic acid-rich fatty acid profile with comparable crystallinity and thermal behavior, while showing significantly enhanced anti-inflammatory activity ( p &lt; 0.05). All extracts and their NLCs were non-irritating and non-cytotoxic. Ethyl acetate extract-based NLCs exhibited favorable particle sizes (72.1 &#xb1; 0.3 nm) and narrow polydispersity (0.14 &#xb1; 0.00), with high-pressure homogenization producing smaller particles compared to probe sonication without affecting IL-6 or TNF-&#x3b1; inhibition. Therefore, A. mellifera brood fat extract is a sustainable anti-inflammatory lipid source with strong potential as an alternative to beeswax in topical nano-formulations.

Propolis and Beeswax in Cosmetics: A Market Survey and Literature Review on Their Relationship and Role in Allergic Contact Dermatitis [PMID: 41663074 · 2026]
de Groot AC, Ipenburg NA, Rustemeyer T · Contact Dermatitis (2026)

Cosmetics have been suggested as sources of exposure in patients with positive patch tests to propolis. It has also been proposed that beeswax in cosmetic products may cause allergic contact dermatitis due to contamination with propolis. To assess how often propolis is listed in cosmetics and to review evidence on the propolis-beeswax relationship, including whether residual propolis in beeswax can elicit dermatitis in propolis-sensitised individuals. Market survey of ingredient lists for 500 cosmetics and a literature review on allergy to beeswax and its association with propolis allergy. None of the 500 cosmetics contained propolis. Evidence on the propolis-beeswax relationship is inconsistent, but occasional co-reactivity is reported. Based on the available evidence, propolis is not or only rarely used in conventional cosmetics on the European market and is therefore unlikely to be a relevant exposure source for patients with positive patch tests to propolis. Reactions to beeswax in propolis-sensitised individuals from residual propolis cannot be fully excluded but appear uncommon and mainly involve allergic contact cheilitis from lip balms. Within the scope of the present data, patients with positive patch tests to propolis do not need to avoid all cosmetics containing beeswax.

Evaluation of the efficacy of local application of bee products in the care of diaper dermatitis in infants: A randomized controlled trial [PMID: 41579432 · 2026]
Aksoy B, Kahriman I, De&#x11f;er O, Atayo&#x11f;lu AT · J Pediatr Nurs (2026)

This randomized controlled trial compared the effects of a barrier cream containing propolis, beeswax, queen bee larvae, and vegetable oil (barrier cream 1) with those of zinc oxide (barrier cream 2) and olive oil on the healing of mild diaper dermatitis (DD). A single-blind, parallel-group, pretest-posttest, repeated-measures randomized controlled trial was conducted. The study included infants aged 1-6&#xa0;months diagnosed with mild DD, who were recruited from three family health centers and a pediatric outpatient clinic in a public hospital in a district of the Mediterranean Region of T&#xfc;rkiye. Data were analysed using descriptive statistics, one-way analysis of variance, chi-square, Bonferroni correction, and generalized estimating equations with multiple logistic regression. The mean DD severity score on days 1, 2, and 3 was lower in the barrier cream 1 group than in the barrier cream 2 and olive oil groups. The mean DD severity score on day 2 of the babies in the barrier cream 1 group was significantly lower than in the other groups (p&#xa0;=&#xa0;.012). Compared to olive oil, barrier cream 1 was 2.54 times (p&#xa0;=&#xa0;.004) more effective, and barrier cream 2 was 1.43 times more effective (p&#xa0;=&#xa0;.192) in improving DD. Barrier cream 1, a formulation containing propolis, beeswax, queen bee larvae, and vegetable oil, demonstrated superior effectiveness in treating mild DD in infants compared to barrier cream 2 and olive oil. Interventions aligned with the ABCDE model positively influenced healing outcomes and enhanced parental satisfaction.

Knowledge and Use of Bee Products in Lithuania [PMID: 41470872 · 2025]
Labokas J, Kleibait&#x117; G · Nutrients (2025)

Background/Objective : In recent years, there has been a growing public interest in natural products, including those derived from bees. While most scientific research on bee products has focused on their pharmacological properties, insufficient attention has been given to consumer knowledge, consumption habits and attitudes. The aim of this study was to estimate the popularity of use of different bee products and assess consumer knowledge about them in Lithuania. Methods : An online survey was carried out of the general adult population of Lithuania with 421 respondents included. Results : The study revealed that honey, beeswax and royal jelly were the best-known bee products, while bee venom was the least known one. Knowledge levels varied by age and occupation of respondents-older people and those working in pharmacy, healthcare, cosmetology, agriculture, beekeeping and food production showed better perception. Honey was most often used for treating colds (78.9%), prevention (78.1%) and reducing fever (65.3%). Dietary use of honey depended on demographic factors and was generally low-28.3% consumed it only a few times per year or less. For cosmetics, propolis was the most used product (34.2%). Conclusions : Older individuals and professionals in pharmacy, healthcare, cosmetology, agriculture, beekeeping and food production, demonstrated better knowledge of bee products. Although honey was rarely consumed as part of the diet, older people tended to use it more often than younger individuals. Men were more likely to use honey for treating digestive and circulatory issues and as an ingredient in food and beverages, whereas women were more inclined to use it for respiratory illnesses and cosmetic treatments.

Anti-Aggregation System for the Enhanced Transdermal Delivery of Cell Membrane-Coated Nanoparticles [PMID: 41365644 · 2025]
Choi B, Lee Y, Kim D, Kim T, Jung S, Choi W, Koh WG, Lee S, Ha SJ, Hong J · ACS Nano (2025)

Biomimetic nanoparticles such as cell membrane-coated nanoparticles (CMNPs) are widely used for the in vivo treatment of various diseases because they offer a high targeting efficiency, excellent biocompatibility, immune evasion capability, and longer circulation times. However, current noninvasive delivery strategies for CMNPs often face limitations regarding maintaining optimal coating stability and distribution efficiency. In this study, we develop a platform for the transdermal delivery of CMNPs as a noninvasive alternative to injections. Specifically, an antiaggregation transdermal delivery tool (AATDT) was developed using biocompatible beeswax and hyaluronic acid. The proposed system reduced the surface energy of the CMNPs, thus preventing aggregation in the liquid phase and promoting skin permeation via enhanced hydration effects. The CMNPs were delivered to a depth of over 500 &#x3bc;m into the skin tissue without aggregation or systemic toxicity. The proposed AATDT thus offers a versatile, clinically translatable strategy for enhancing the stability and delivery efficiency of CMNPs in noninvasive therapeutic applications.

Interventions for the Prevention and Management of Nipple Trauma in Breastfeeding Women: A Systematic Review [PMID: 42278799 · 2026]
Kirimlidou S, Dagla M, Palaska E, et al. · Healthcare (Basel) (2026)

Background/Objectives: Nipple trauma is one of the most common complications during breastfeeding and may lead to pain, discomfort, and the premature cessation of lactation. This systematic review aimed to synthesize and critically appraise recent evidence (2020-2026), reflecting current clinical practices and emerging interventions, for the prevention and management of nipple trauma in breastfeeding women. The primary emphasis was on pain reduction and healing with a secondary consideration of their impact on breastfeeding continuation and duration. Methods: The review was conducted according to the PRISMA guidelines and included a literature search in the PubMed and Scopus databases. Primary research studies published between 2020 and 2026 focusing on interventions in breastfeeding women experiencing nipple trauma or nipple pain were included. A total of 22 studies met the inclusion criteria. Results: The interventions included the topical applications of natural products such as olive oil, expressed breast milk, coconut oil, beeswax-based products, and lanolin, nipple shields, and educational interventions focusing on correct breastfeeding techniques. The findings suggest that several of these interventions may reduce nipple pain and promote the healing of nipple trauma, while breastfeeding education and professional support appear to improve breastfeeding experience and continuation. Conclusions: The heterogeneity of the included studies highlights the need for further well-designed clinical research.

Gelation in Oleogels: A Rheological Framework for Soft Material Formulation [PMID: 42201878 · 2026]
Patel S, Agarwal K, Arnipally S, et al. · Langmuir (2026)

Oleogels formed using natural waxes undergo a sol-gel transition as the temperature decreases. Such a transition is due to the formation of a hierarchical three-dimensional crystalline network formed by the wax crystals. The properties at the interfaces of these crystals play a crucial role in shaping the overall viscoelastic response of bulk materials. Although this transition governs their processing and functional performance, it has not been examined using critical gelation theory. In this work, we investigate the sol-gel transition in beeswax-corn oil oleogels by performing a detailed linear viscoelastic analysis. When subjected to an oscillatory shear flow field while decreasing temperature, the dynamic moduli exhibit an identical power-law dependence on frequency at a certain temperature, confirming the existence of a critical gel state. We also obtain various critical scaling relations with respect to different linear viscoelastic properties in the pre-gel and post-gel states. Remarkably, the corresponding scaling exponents satisfy the hyperscaling relations, validating the critical gelation framework. We also quantify the effects of wax concentration, which cause an increase in the fractal dimension as well as the gel strength. We believe that this study provides the first comprehensive validation of the critical gelation theory for wax-based oleogels. This work also establishes a unified linear viscoelastic description of their sol-gel transition, offering a predictive framework for formulation and processing near the gel point. Finally, we create a logical design framework for manipulating the mechanical stiffness and thermal durability of oleogels for various applications, such as shape-retaining cosmetics and spreadable food products. This is achieved by correlating the scaling behavior with the composition as well as the thermal history of the oleogels.

Qualitative phytochemical profiling, antioxidant activity, and development of a water-in-oil cream containing combined oil and water infusions of frankincense resin (Boswellia spp.): a preliminary in vitro study [PMID: 42130642 · 2026]
Javed S, Salawi A, Moni SS, et al. · J Pharm Pharm Sci (2026)

Frankincense (gum olibanum, Boswellia spp.) is an oleo-gum resin widely used in traditional medicine and cosmetics owing to the presence of volatile oils and pentacyclic triterpenic acids (boswellic acids) with reported anti-inflammatory and antioxidant properties. The aim of this study was to extract and characterize oil- and water-soluble fractions of frankincense resin, evaluate their antioxidant potential, and incorporate them into a stable water-in-oil ( w/o ) nourishing/antiaging cream. Frankincense resin was ground and macerated separately in sweet almond oil and Madinah rosewater to yield oil and water infusions, respectively. Qualitative phytochemical tests and FT-IR spectroscopy were employed for the characterization of both extracts and final formulations. Antioxidant potential was assessed using the DPPH assay followed by the development of a w/o cream (beeswax:almond oil:rosewater base) using combined infusions, which was evaluated for pH, viscosity, phase separation, spreadability, and thermal stability. Phytochemical screening showed presence of triterpenoids and boswellic type functionalities predominantly in the oil infusion, whereas saponins and minor alkaloids were detected in the water infusion. In the DPPH assay, significant free radical scavenging activity was observed as sample 2 showed 71% inhibition at 343.46 &#xb1; 34.2&#xa0;&#x3bc;g/mL. The developed cream formulation showed good physical stability, acceptable pH and shear-thinning rheology. A stable, all-natural w/o cream formulation was developed incorporating combined oil- and water-soluble frankincense infusions. Future studies are warranted to perform quantitative chemical analysis, in vitro skin permeation, and formal skin safety testing to ensure uninform active content, good bioavailability and tolerability prior to clinical studies.

Reproducing an Edo Period Orbital Epithesis with Wood and Crystal [PMID: 41886392 · 2026]
Yoshida K · J Hist Dent (2026)

In Japan, ophthalmic diseases, such as gonorrheal conjunctivitis, were widespread during the Edo period (1603-1868), leaving many patients without one or both eyes. Numerous records indicate that many professional denturists often crafted artificial eyes for such patients; however, no evidence of inserted prosthetic eyes has been found to date. The author aimed to recreate a wooden orbital epithesis using the same materials and methods as those used in the Edo period where boxwood was used for wooden plate dentures. The inner surface of the epithesis could be contaminated with mucus; therefore, raw lacquer was applied similar to that applied to Noh masks. The artificial eye was fabricated using Japanese crystal, which was used for gyokugan (inlaid crystal eyes) in Buddhist statues in Japan for 900 years. The crystal was formed and polished with whetstones, and the skin surface was painted with Japanese paints and finished with beeswax. The method of orbital epithesis fixation remains unknown, and the possibility of using an adhesive was considered. The author's initial trial indicated that a relatively realistic orbital epithesis could be recreated. Highly skillful Edo-period denturists were likely to have fabricated considerably more sophisticated artificial eyes.

Ensuring the Safe Use of Bee Products: A Review of Allergic Risks and Management [PMID: 41465502 · 2025]
Matuszewska-Mach E, Borysewicz P, Królak J, et al. · Int J Mol Sci (2025)

Honeybee products (HBPs), including honey, bee pollen, bee bread, royal jelly, propolis, beeswax, and bee brood, are increasingly used in food, nutraceutical, and cosmetic contexts. Because of their natural origin, HBPs can provoke allergic reactions ranging from localised dermatitis to life-threatening, systemic anaphylaxis. As the use of bee products for health purposes grows in apitherapy (a branch of alternative medicine), raising public awareness of their potential risks is essential. This narrative review synthesises the clinical manifestations of HBP allergy, culprit allergens present in each product, immunological mechanisms, diagnostic approaches, at-risk populations, and knowledge gaps. The analysis of the available literature suggests that, although relatively rarely, HPB may trigger allergic reactions, including anaphylactic shock. The sensitisation mechanism may be associated with both primary sensitisation and cross-reactivity and can be classified into type I (IgE-mediated) and type IV (T-cell-mediated). However, bee bread appears less allergenic than other HBPs, potentially due to lactic fermentation that can degrade allergenic proteins. Severe reactions following intake of bee bread have not been reported to date. Management of HBP allergic reactions centres on avoiding the products, educating about the risks, and providing more precise product labelling, specifying the allergen content. Individuals with atopy and beekeepers are at heightened risk of developing anaphylaxis; therefore, they should be particularly aware of the potential dangerous consequences of HPB use. Further research is needed to clarify the mechanisms of HBP allergies and improve safety for all users.

Bioinspired Heat-Induced Viscoelasticity-Switchable Electrodes for Conformal Brain-Computer Interfaces [PMID: 41457672 · 2026]
Cai Z, Zhang S, Wang J, et al. · Adv Mater (2026)

Electroencephalography is a promising noninvasive modality for brain-computer interfaces (BCIs), yet its widespread adoption is constrained by electrode limitations: dry electrodes yield unstable signals, whereas wet electrodes require laborious setup and are ill-suited to wearable devices. Inspired by honeybees that locally heat beeswax to reversibly switch it between rigid and moldable states for comb construction, this work introduces a heat-induced viscoelasticity-switchable electrode (HIVE) that enables conformal contact on hairy scalps and user-friendly operation in wearable systems. HIVE integrates a thermoresponsive gelatin gel confined in a sponge matrix with an on-electrode microheater. Its temperature is actively modulated on demand, enabling autonomous switching between the gel and sol states. As a flowable sol, it permeates hair, conforms to the skin. At body temperature, it remains in a viscoelastic state, providing strong adhesion. Moreover, heating duration is closed-loop controlled using real-time electrode-skin impedance. In steady-state visual evoked potential paradigm, HIVE delivers high classification accuracy comparable to gold-standard wet electrodes while supporting wearable BCI devices for vision-based wheelchair navigation and high-speed text entry. By translating honeybee viscoelasticity-modulation strategy into bioelectronic interfaces, this work provides a practical solution for wearable BCI devices and a new design paradigm for conformal biointerfaces on hairy or piliferous surfaces.

자주 묻는 질문 (AEO 스니펫 최적화 FAQ)

Q1. 비즈왁스 (BEESWAX)의 국가별 공식 전성분 표기명은 어떻게 다른가요?
한국 식약처 표준명은 '비즈왁스', 미국 PCPC 및 유럽 CosIng INCI 표기는 'BEESWAX', 중국 NMPA IECIC 표준명은 '蜂蜡', 일본 화장품 표시명칭은 'ミツロウ'입니다.
Q2. 비즈왁스의 글로벌 6대 권역 법정 배합 한도(Layer 1)는 무엇인가요?
한국(KR: none), 유럽(EU: none), 미국(US: none), 중국(CN: allowed), 일본(JP: none), 아세안(ASEAN: none) 고시 기준을 준수하여 처방해야 합니다.
Q3. 제형 설계 시 비즈왁스의 통상 배합 농도(Layer 3)와 적정 pH는 얼마인가요?
대표 제형군(emulsion_cream) 기준 통상 0.3~15%(권장 중앙값 1.5%) 범위로 투입하며, 적정 pH는 4~8입니다.
Q4. 비즈왁스 배합 시 주의해야 할 상용성 금기(Incompatibilities)와 시너지 성분은 무엇인가요?
주요 권장 시너지 조합은 GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL이며, 배합 주의사항은 처방 내 극단적 pH 조건 및 고농도 전해질과의 상용성 사전 확인 권장입니다.